Neoadjuvant lazertinib with or without chemotherapy for patients with epidermal growth factor receptor (EGFR)-mutated resectable non-small cell lung cancer (NSCLC): NeoLazer trial. This is an ASCO ...
Not open for further replies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results